Systems immunogenetics of vaccines

Seminars in Immunology

Volumn 25, Issue 2, 2013, Pages 124-129

  Mooney, Michael ^a,b   McWeeney, Shannon ^a,b   Sékaly, Rafick Pierre ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon Clinic   (United States)

^c Vaccine and Gene Therapy Institute of Florida   (United States)

Author keywords

Infectious disease; Systems biology; Vaccine

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HLA ANTIGEN; HOST FACTOR; INFLUENZA VACCINE; VACCINE; YELLOW FEVER VACCINE;

ACCURACY; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EPISTASIS; GENE DELETION; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS C; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENETICS; INFLUENZA; LEPROSY; MALARIA; MENINGOCOCCOSIS; METABOLOMICS; NONHUMAN; PHARMACOGENOMICS; POPULATION GENETICS; PREDICTION; PROTEIN INTERACTION; PROTEOMICS; REVIEW; SUPPORT VECTOR MACHINE; TRANSCRIPTOMICS; TUBERCULOSIS; VACCINATION;

INFECTIOUS DISEASE; SYSTEMS BIOLOGY; VACCINE;

ANIMALS; DRUG DISCOVERY; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, ACTIVE; IMMUNOGENETICS; MOLECULAR TARGETED THERAPY; SYSTEMS BIOLOGY; VACCINES;

EID: 84882264985     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.06.003     Document Type: Review

References (65)

1. Poland G.A., Kennedy R.B., Ovsyannikova I.G. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?. PLoS Pathog 2011, 7(December (12)):e1002344.
2. Rappuoli R., Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 2011, 473(May (7348)):463-469. 10.1038/nature10124.
3. Pulendran B., Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011, 12(June (6)):509-517.
4. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449(September (7161)):419-426.
5. Brusic V., August J.T. The changing field of vaccine development in the genomics era. Pharmacogenomics 2004, 5(September (6)):597-600.
6. Nair N., Gans H., Lew-Yasukawa L., Long-Wagar A.C., Arvin A., Griffin D.E. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. J Infect Dis 2007, 196(November (9)):1339-1345.
7. Green M.S., Shohat T., Lerman Y., Cohen D., Slepon R., Duvdevani P., et al. Sex differences in the humoral antibody response to live measles vaccine in young adults. Int J Epidemiol 1994, 23(October (5)):1078-1081.
8. Hsu L.C., Lin S.R., Hsu H.M., Chao W.H., Hsieh J.T., Wang M.C., et al. Ethnic differences in immune responses to hepatitis B vaccine. Am J Epidemiol 1996, 143(April (7)):718-724.
9. Winter A.P., Follett E.A., McIntyre J., Stewart J., Symington I.S. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine 1994, 12(July (9)):771-772.
10. Oyston P., Robinson K. The current challenges for vaccine development. J Med Microbiol 2012, 61(July (Pt. 7)):889-894.
11. Trautmann L., Sekaly R.P. Solving vaccine mysteries: a systems biology perspective. Nat Immunol 2011, 12(July 8):729-731.
12. Aderem A., Adkins J.N., Ansong C., Galagan J., Kaiser S., Korth M.J., et al. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. MBio 2011, 2(March (1)). e00325-10.
13. Zak D.E., Aderem A. Systems biology of innate immunity. Immunol Rev 2009, 227(Jane (1)):264-282.
14. Bumann D. System-level analysis of Salmonella metabolism during infection. Curr Opin Microbiol 2009, 12(October (5)):559-567.
15. Peng X., Chan E.Y., Li Y., Diamond D.L., Korth M.J., Katze M.G. Virus-host interactions: from systems biology to translational research. Curr Opin Microbiol 2009, 12(August (4)):432-438.
16. Nadeau J.H., Dudley A.M., Genetics Systems genetics. Science 2011, 331(February (6020)):1015-1016.
17. Barabási A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011, 12(Jane (1)):56-68.
18. Ideker T., Krogan N.J. Differential network biology. Mol Syst Biol 2012, 8:565.
19. Franzosa E.A., Garamszegi S., Xia Y. Toward a three-dimensional view of protein networks between species. Front Microbiol 2012, 3:428.
20. Maecker H.T., McCoy J.P., Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol 2012, 12(February (3)):191-200.
21. Bandura D.R., Baranov V.I., Ornatsky O.I., Antonov A., Kinach R., Lou X., et al. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 2009, 81(August (16)):6813-6822.
22. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10(Jane (1)):116-125.
23. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011, 12(July (8)):786-795.
24. Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008, 205(December (13)):3119-3131.
25. Lee E.K. Large-scale optimization-based classification models in medicine and biology. Ann Biomed Eng 2007, 35(June (6)):1095-1109.
26. Brooks J.P., Lee E.K. Analysis of the consistency of a mixed integer programming-based multi-category constrained discriminant model. Ann Oper Res 2008, 164:1-20.
27. Andersen-Nissen E., Heit A., McElrath M.J. Profiling immunity to HIV vaccines with systems biology. Curr Opin HIV AIDS 2012, 7(Jane (1)):32-37.
28. Allison A.C. Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J 1954, 1:290-294.
29. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
30. Newport M.J., Finan C. Genome-wide association studies and susceptibility to infectious diseases. Brief Funct Genomics 2011, 10(March (2)):98-107.
31. van Manen D., van 't Wout A.B., Schuitemaker H. Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics. Retrovirology 2012, 9:70.
32. Fellay J., Shianna K.V., Ge D., Colombo S., Ledergerber B., Weale M., et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317(August (5840)):944-947.
33. McKinney B.A., Pajewski N.M. Six degrees of epistasis: statistical network models for GWAS. Front Genet 2011, 2:109.
34. Fätkenheuer G., Pozniak A.L., Johnson M.A., Plettenberg A., Staszewski S., Hoepelman A.I., et al. Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med 2005, 11(November (11)):1170-1172.
35. Khor C.C., Hibberd M.L. Host-pathogen interactions revealed by human genome-wide surveys. Trends Genet 2012, 28(May (5)):233-243.
36. Borrell S., Gagneux S. Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2011, 17(June (6)):815-820.
37. Kryazhimskiy S., Dushoff J., Bazykin G.A., Plotkin J.B. Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet 2011, 7(February (2)):e1001301.
38. Daugherty M.D., Malik H.S. Rules of engagement: molecular insights from host-virus arms races. Annu Rev Genet 2012, 46:677-700.
39. Desmond-Hellman S. Toward precision medicine: a new social contract?. Sci Transl Med 2012, 4(129):1-2.
40. Katsnelson A. Momentum grows to make 'personalized' medicine more 'precise'. Nat Med 2013, 19(March (3)):249.
41. Tan P.L., Jacobson R.M., Poland G.A., Jacobsen S.J., Pankratz V.S. Twin studies of immunogenicity-determining the genetic contribution to vaccine failure. Vaccine 2001, 19(March (17-19)):2434-2439.
42. St Sauver J.L., Dhiman N., Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Pankratz V.S., et al. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. Hum Immunol 2005, 66(July (7)):788-798.
43. Fellay J., Ge D., Shianna K.V., Colombo S., Ledergerber B., Cirulli E.T., et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009, 5(December (12)):e1000791. PMID: 20041166.
44. Pelak K., Goldstein D.B., Walley N.M., Fellay J., Ge D., Shianna K.V., et al. Host determinants of HIV-1 control in African Americans. J Infect Dis 2010, 201(April (8)):1141-1149. 10.1086/651382. PMID: 20205591.
45. International HIV Controllers Study, Pereyra F., Jia X., McLaren P.J., Telenti A., de Bakker P.I., et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330(December (6010)):1551-1557. PMID: 21051598.
46. Petrovski S., Fellay J., Shianna K.V., Carpenetti N., Kumwenda J., Kamanga G., et al. Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS 2011, 25(February (4)):513-518. PMID: 21160409.
47. Lingappa J.R., Petrovski S., Kahle E., Fellay J., Shianna K., McElrath M.J., et al. Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. PLoS ONE 2011, 6(12):e28632. PMID: 22174851.
48. Le Clerc S., Limou S., Coulonges C., Carpentier W., Dina C., Taing L., et al. Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis 2009, 200(October (8)):1194-1201. PMID: 19754311.
49. Limou S., Le Clerc S., Coulonges C., Carpentier W., Dina C., Delaneau O., ANRS Genomic Group, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009, 199(February (3)):419-426. PMID: 19115949.
50. Kennedy R.B., Ovsyannikova I.G., Pankratz V.S., Haralambieva I.H., Vierkant R.A., Poland G.A. Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet 2012, 131(September (9)):1403-1421. PMID: 22610502.
51. Ovsyannikova I.G., Kennedy R.B., O'Byrne M., Jacobson R.M., Pankratz V.S., Poland G.A. Genome-wide association study of antibody response to smallpox vaccine. Vaccine 2012, 30(June (28)):4182-4189. PMID: 22542470.
52. Zhou J., To K.K., Dong H., Cheng Z.S., Lau C.C., Poon V.K., et al. A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection. J Infect Dis 2012, 206(August (4)):495-503. PMID: 22693232.
53. Kamatani Y., Wattanapokayakit S., Ochi H., Kawaguchi T., Takahashi A., Hosono N., et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009, 41(May (5)):591-595. PMID: 19349983.
54. Mbarek H., Ochi H., Urabe Y., Kumar V., Kubo M., Hosono N., et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 2011, 20(October (19)):3884-3892. PMID: 21750111.
55. Liu L., Li J., Yao J., Yu J., Zhang J., Ning Q., et al. A genome-wide association study with DNA pooling identifies the variant rs11866328 in the GRIN2A gene that affects disease progression of chronic HBV infection. Viral Immunol 2011, 24(October (5)):397-402. PMID: 22004137. 10.1089/vim.2011.0027.
56. Png E., Thalamuthu A., Ong R.T., Snippe H., Boland G.J., Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet 2011, 20(October (19)):3893-3898. PMID: 21764829.
57. Rauch A., Kutalik Z., Descombes P., Cai T., Di Iulio J., Mueller T., et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010, 138(April (4)):1338-1345. 1345.e1-7. PMID: 20060832.
58. Pajewski N.M., Shrestha S., Quinn C.P., Parker S.D., Wiener H., Aissani B., et al. A genome-wide association study of host genetic determinants of the antibody response to anthrax vaccine adsorbed. Vaccine 2012, 30(July (32)):4778-4784. PMID: 22658931.
59. Zhang F.R., Huang W., Chen S.M., Sun L.D., Liu H., Li Y., et al. Genomewide association study of leprosy. N Engl J Med 2009, 361(December (27)):2609-2618. PMID: 20018961.
60. Zhang F., Liu H., Chen S., Low H., Sun L., Cui Y., et al. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet 2011, 43(October (12)):1247-1251. PMID: 22019778.
61. Jallow M., Teo Y.Y., Small K.S., Rockett K.A., Deloukas P., Clark T.G., et al. Wellcome trust case control consortium; malaria genomic epidemiology network, genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 2009, 41(June (6)):657-665. PMID: 19465909.
62. Timmann C., Thye T., Vens M., Evans J., May J., Ehmen C., et al. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature 2012, 489(September (7416)):443-446. PMID: 22895189.
63. Davila S., Wright V.J., Khor C.C., Sim K.S., Binder A., Breunis W.B., et al. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet 2010, 42(September (9)):772-776. PMID: 20694013.
64. Thye T., Vannberg F.O., Wong S.H., Owusu-Dabo E., Osei I., Gyapong J., et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 2010, 42(September (9)):739-741. PMID: 20694014.
65. Thye T., Owusu-Dabo E., Vannberg F.O., van Crevel R., Curtis J., Sahiratmadja E., et al. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet 2012, 44(February (3)):257-259. PMID: 22306650.